Related Experiment Video
Updated: Oct 21, 2025

08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.6K
Catheter position prediction using deep-learning-based multi-atlas registration for high-dose rate prostate
Yang Lei1, Tonghe Wang1, Yabo Fu1
1Department of Radiation Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Medical Physics
|September 4, 2021
Summary
This study introduces a new AI method to guide catheter placement in high-dose-rate (HDR) prostate brachytherapy, improving treatment plan quality and reducing physician variability.
Area of Science:
- Medical Physics
- Radiation Oncology
- Artificial Intelligence in Medicine
Background:
- Catheter placement in high-dose-rate (HDR) prostate brachytherapy is currently empirical and physician-dependent.
- This variability can lead to uncertainty in treatment plan quality and suboptimal dose distribution.
Purpose of the Study:
- To develop and evaluate a learning-based method for guiding catheter placement in HDR prostate brachytherapy.
- To reduce physician dependence on experience and improve prostate cancer treatment plan quality.
Main Methods:
- A framework combining deformable registration (Reg-Net), multi-atlas ranking, and catheter regression was developed.
- Distance maps of prostate and organs-at-risk were used for registration and atlas ranking based on similarity and catheter position criteria.
- A retrospective study on 90 patients with fivefold cross-validation evaluated the method's feasibility and impact on dose metrics.
Main Results:
- The proposed method achieved comparable dose coverage (V100 = 95%) to clinical plans.
- Plans from predicted catheter patterns showed slightly increased hotspots (V150 by 5.0%, V200 by 2.9%) on average.
- Organ-at-risk dose constraints showed minimal average differences (within ±1 cc) for bladder, rectum, and urethra.
Conclusions:
- A novel deep-learning-based multi-atlas registration algorithm for catheter placement prediction in HDR prostate brachytherapy was developed.
- The method shows significant clinical potential for improving treatment plan quality and consistency.
- Further clinical evaluation is warranted to validate its role in quality control for HDR prostate brachytherapy.

